-
Pipeline
Inflammatory
Createrna has several drugs for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, etc., and several projects have entered the clinical research stage.
-
Field
-
Program
-
Indications
-
PCC
-
IND-Enabling
-
IND
-
Clinical Phase I
-
Clinical Phase Ⅱ
-
Clinical Phase Ⅲ
-
Info
Inflammatory
-
MY004
RA/Psoriasis/SLE/AD
-
MY009
IBD
-
QR065
IBD
Inflammatory
Program:MY004
Indications:RA/Psoriasis/SLE/AD
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Inflammatory
Program:MY009
Indications:IBD
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Inflammatory
Program:QR065
Indications:IBD
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Respiratory System
Createrna is researching in IgA nephropathy, FSGS, diabetic nephropathy and other indications.
-
Field
-
Program
-
Indications
-
PCC
-
IND-Enabling
-
IND
-
Clinical Phase I
-
Clinical Phase Ⅱ
-
Clinical Phase Ⅲ
-
Info
Respiratory System
-
QR052
RCC/SAC/Chronic Pain
-
QR060
Chronic Pain/Cough
-
QR056251
IPF
-
QR056240
IPF
-
QR057
Cough
-
QR055
IPF
Respiratory System
Program:QR052
Indications:RCC/SAC/Chronic Pain
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Respiratory System
Program:QR060
Indications:Chronic Pain/Cough
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Respiratory System
Program:QR056251
Indications:IPF
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Respiratory System
Program:QR056240
Indications:IPF
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Respiratory System
Program:QR057
Indications:Cough
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Respiratory System
Program:QR055
Indications:IPF
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Kidney System
Createrna has a number of projects in chronic cough and idiopathic pulmonary fibrosis, and has already entered the clinical and IND phase.
-
Field
-
Program
-
Indications
-
PCC
-
IND-Enabling
-
IND
-
Clinical Phase I
-
Clinical Phase Ⅱ
-
Clinical Phase Ⅲ
-
Info
Kidney System
-
MY008
PNH/IgA nephropathy
-
QR059
PNH
-
MY004
IgA nephropathy
Kidney System
Program:MY008
Indications:PNH/IgA nephropathy
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Kidney System
Program:QR059
Indications:PNH
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Kidney System
Program:MY004
Indications:IgA nephropathy
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ
Cardiovascular System
Createrna has several projects under research in essential hypertension, chronic heart failure, anticoagulation and other indications, and has entered the clinical research stage.
-
Field
-
Program
-
Indications
-
PCC
-
IND-Enabling
-
IND
-
Clinical Phase I
-
Clinical Phase Ⅱ
-
Clinical Phase Ⅲ
-
Info
Cardiovascular System
-
QR12000（QR01019）
EH
Cardiovascular System
Program:QR12000（QR01019）
Indications:EH
PCC
IND-Enabling
IND
Clinical Phase I
Clinical Phase Ⅱ
Clinical Phase Ⅲ